The Experts below are selected from a list of 621 Experts worldwide ranked by ideXlab platform
André Dallmann - One of the best experts on this subject based on the ideXlab platform.
-
Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling
Clinical Pharmacokinetics, 2020Co-Authors: Jeremiah D. Momper, Gilbert J. Burckart, Natella Y. Rakhmanina, Dionna J. Green, Tim R. Cressey, Mark Mirochnick, Brookie M. Best, John N. Anker, André DallmannAbstract:Background Predicting Drug pharmacokinetics in pregnant women including Placental Drug Transfer remains challenging. This study aimed to develop and evaluate maternal–fetal physiologically based pharmacokinetic models for two antiretroviral Drugs, dolutegravir and raltegravir.
Jeremiah D. Momper - One of the best experts on this subject based on the ideXlab platform.
-
Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling
Clinical Pharmacokinetics, 2020Co-Authors: Jeremiah D. Momper, Gilbert J. Burckart, Natella Y. Rakhmanina, Dionna J. Green, Tim R. Cressey, Mark Mirochnick, Brookie M. Best, John N. Anker, André DallmannAbstract:Background Predicting Drug pharmacokinetics in pregnant women including Placental Drug Transfer remains challenging. This study aimed to develop and evaluate maternal–fetal physiologically based pharmacokinetic models for two antiretroviral Drugs, dolutegravir and raltegravir.
Brookie M. Best - One of the best experts on this subject based on the ideXlab platform.
-
Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling
Clinical Pharmacokinetics, 2020Co-Authors: Jeremiah D. Momper, Gilbert J. Burckart, Natella Y. Rakhmanina, Dionna J. Green, Tim R. Cressey, Mark Mirochnick, Brookie M. Best, John N. Anker, André DallmannAbstract:Background Predicting Drug pharmacokinetics in pregnant women including Placental Drug Transfer remains challenging. This study aimed to develop and evaluate maternal–fetal physiologically based pharmacokinetic models for two antiretroviral Drugs, dolutegravir and raltegravir.
John N. Anker - One of the best experts on this subject based on the ideXlab platform.
-
Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling
Clinical Pharmacokinetics, 2020Co-Authors: Jeremiah D. Momper, Gilbert J. Burckart, Natella Y. Rakhmanina, Dionna J. Green, Tim R. Cressey, Mark Mirochnick, Brookie M. Best, John N. Anker, André DallmannAbstract:Background Predicting Drug pharmacokinetics in pregnant women including Placental Drug Transfer remains challenging. This study aimed to develop and evaluate maternal–fetal physiologically based pharmacokinetic models for two antiretroviral Drugs, dolutegravir and raltegravir.
Gilbert J. Burckart - One of the best experts on this subject based on the ideXlab platform.
-
Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling
Clinical Pharmacokinetics, 2020Co-Authors: Jeremiah D. Momper, Gilbert J. Burckart, Natella Y. Rakhmanina, Dionna J. Green, Tim R. Cressey, Mark Mirochnick, Brookie M. Best, John N. Anker, André DallmannAbstract:Background Predicting Drug pharmacokinetics in pregnant women including Placental Drug Transfer remains challenging. This study aimed to develop and evaluate maternal–fetal physiologically based pharmacokinetic models for two antiretroviral Drugs, dolutegravir and raltegravir.